Agilent Technologies expands microarray offering
Agilent Technologies has introduced the industry\'s first shared microarray design programme. The programme presents a new way of doing business that allows scientists to share their custom microarray designs with either designated groups, while maintaining control of their intellectual property, or with the scientific community at large.
Agilent Technologies has introduced the industry's first shared microarray design programme. The programme presents a new way of doing business that allows scientists to share their custom microarray designs with either designated groups, while maintaining control of their intellectual property, or with the scientific community at large.
Other key benefits for researchers include: flexibility of design without the burdens of production; each microarray assigned an order number, allowing easy and speedy ordering; full integration with Agilent's end-to-end gene expression solution, and high sensitivity, with each microarray having the sensitivity of Agilent's 60-mer oligonucleotide printing technology.
The programme is expected to particularly benefit scientists in consortia working collaboratively on the study of specific organisms, with Caenorhabditis elegans, a worm that is a popular model organism for research, and Magnaporthe grisea, a fungus that causes rice blast disease, becoming the first two to be made available through the program.
'This program gives the Toxicogenomics Research Consortium, as well as the rest of the scientific community, access to commercial-quality microarrays designed with our latest sequence information and updated as frequently as we desire,' said Pat Hurban, director of Investigational Genomics at Icoria Inc. 'Those are huge benefits that help promote collaboration across industry and academia.'